IP Library › Granted Patent US 7,915,309
Granted Patent B2
US 7,915,309 · App. 11/765,668 · Granted Mar 29, 2011

Deuterium-enriched oseltamivir

Assignee: Protia, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,915,309
App. No.
11/765,668
Granted
Mar 29, 2011
Kind
B2
Abstract

The present application describes deuterium-enriched oseltamivir, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.

Claims (6)

1. A deuterium-enriched compound of the formula:

or a pharmaceutically acceptable salt form thereof.

2. A pharmaceutical composition, comprising: a pharmaceutically acceptable carrier and a therapeutically effective amount of the compound of formula:

or a pharmaceutically acceptable salt form thereof.

3. A method for treating a disease selected from Influenza virus A and Influenza virus B comprising: administering, to a patient in need thereof, a therapeutically effective amount of the compound of formula:

or a pharmaceutically acceptable salt form thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2013
From: DEUTERIA PHARMACEUTICALS INC
To: PROTIA, LLC
Reel/Frame 029732/0858 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2011
From: PROTIA, LLC
To: DEUTERIA PHARMACEUTICALS INCE
Reel/Frame 026609/0689 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2008
From: CZARNIK, ANTHONY W
To: PROTIA, LLC
Reel/Frame 021733/0840 →
Continuity (1)
Related Publication 20080319064A1 · Dec 25, 2008